Symbol: |
FAHD1
|
Description: |
fumarylacetoacetate hydrolase domain containing 1 [Source:HGNC Symbol;Acc:14169]
|
Location: |
Chr16:1876968-1890208[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:150
Gene |
Compound |
Gen_sig |
Exp_pattern |
FAHD1 |
NSC 106442 |
0.001 |
Down |
FAHD1 |
Ethanesulfonic acid, compd. with 5-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy]propyl]carbamoyl]-o-toluenesulfonyl fluoride (1:1) |
0.03 |
Up |
FAHD1 |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.026 |
Up |
FAHD1 |
NSC 13477 |
0.017 |
Down |
FAHD1 |
Benzamide, N-[2-(diethylamino)ethyl]-4-methyl-2-nitro- 3-(phenylmethoxy)- |
0.041 |
Down |
FAHD1 |
STREPTOVARICIN G |
0.002 |
Down |
FAHD1 |
NSC 16857 |
0.015 |
Down |
FAHD1 |
Pimozide |
0.034 |
Down |
FAHD1 |
1H-Pyrazole-1-ethanol, 4,4'-azoxybis(3,5-dimethyl- |
0.003 |
Down |
FAHD1 |
NSC 212446 |
0.028 |
Up |
FAHD1 |
Buclizine Hydrochloride |
0.03 |
Down |
FAHD1 |
Phenol, 4,4'-methylenebis[2-[(propylimino)methyl]- |
0.047 |
Up |
FAHD1 |
NSC 26669 |
0.022 |
Down |
FAHD1 |
1,7-Heptanediamine, N,N'-bis(2-methyl-7-nitro-4-quinolinyl)-, dihydrochloride |
0.032 |
Up |
FAHD1 |
Mitoxantrone |
0.033 |
Up |
Expression pattern: Sensitivity / Resistance
Total:10 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:46
Total:4 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:33
Gene |
Gen_transcript |
miRNA |
miR_location |
FAHD1 |
ENST00000326061 |
hsa-mir-606 |
Chr10:77312276-77312296[+] |
FAHD1 |
ENST00000326061 |
hsa-mir-609 |
Chr10:105978607-105978626[-] |
FAHD1 |
ENST00000326061 |
hsa-mir-93-5p |
Chr7:99691438-99691460[-] |
|